Carlos F. Barbas III (1964 – 2014)

  • ChemPubSoc Europe Logo
  • Author: ChemViews Magazine
  • Published Date: 27 June 2014
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Carlos F. Barbas III (1964 – 2014)

Professor Carlos F. Barbas III, The Scripps Research Institute (TSRI), La Jolla, CA, USA, passed away last Tuesday.

Barbas will be remembered for his work on therapeutic antibodies, vaccines, and zinc-finger technology. He was also advancing the science of asymmetric catalysis with organic molecules through studies at the interfaces of chemistry, biology, and medicine and was one of the key players in organocatalysis. Additionally, he was involved in the development of new classes of drugs and vaccines for cancer and HIV-1.


Carlos F. Barbas
was born November 5, 1964. After he gained his Ph.D. in Organic Chemistry from Texas A&M University, College Station, TX, USA, in 1989, he went for a postdoctoral fellowship with Richard Lerner and Steven Benkovic to The Scripps Research Institute and the Pennsylvania State University from 1989–1991. From 1991–1995 he was Assistant Professor, The Scripps Research Institute, Department of Molecular Biology, and from 1995–2000 Associate Professor there.

Since 1992, Barbas was Director of the Cold Spring Harbor Laboratory Annual Fall Course on "Phage Display Of Proteins & Peptides", NY, USA, since 1997 Janet and W. Keith Kellogg II Endowed Chair in Molecular Biology and since 2000 Kellogg Professor, The Scripps Research Institute, Department of Molecular Biology and Chemistry.

Barbas has been honored with numerous awards, including the Arthur C. Cope Scholar Award and the Tetrahedron Young Investigator Award in Bioorganic & Medicinal Chemistry in 2009. Since 2003, Barbas is an ISI Highly Cited Researcher, and from 1992–1995 Scholar of The American Foundation for AIDS Research.




Also of interest:

Article Views: 9225

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH